Tarsus Pharmaceuticals, Inc. SEC filings TARS
Tarsus Pharmaceuticals, Inc. has 676 filings in SEC EDGAR's recent list, going back to Aug 7, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Oct 13, 2026 | — |
| S-3ASR | Automatic shelf registration | Oct 13, 2026 | — |
| S-8 | Employee stock plan registration | Feb 23, 2026 | — |
| 424B5 | Prospectus supplement | Mar 13, 2025 | — |
| 424B5 | Prospectus supplement | Mar 12, 2025 | — |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 29, 2024 | — |
| S-8 | Employee stock plan registration | Feb 27, 2024 | — |
| S-3 | Shelf registration | Nov 9, 2023 | — |
| 424B5 | Prospectus supplement | Aug 2, 2023 | — |
| 424B5 | Prospectus supplement | Jul 31, 2023 | — |
| S-8 | Employee stock plan registration | Mar 17, 2023 | — |
| 424B5 | Prospectus supplement | May 4, 2022 | — |
| FWP | Free writing prospectus | May 3, 2022 | — |
| 424B5 | Prospectus supplement | May 2, 2022 | — |
| S-8 | Employee stock plan registration | Mar 14, 2022 | — |
| S-3 | Shelf registration | Nov 1, 2021 | — |
| S-8 | Employee stock plan registration | Mar 31, 2021 | — |
| S-8 | Employee stock plan registration | Oct 20, 2020 | — |
| 424B4 | Prospectus | Oct 16, 2020 | — |
| S-1MEF | Filing | Oct 15, 2020 | — |
| S-1/A | Amended registration statement | Oct 9, 2020 | — |
| S-1 | Registration statement | Sep 25, 2020 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TARS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1819790
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.